Suppr超能文献

肥胖活体供肾者的肾脏结局研究。

A study of renal outcomes in obese living kidney donors.

机构信息

Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

出版信息

Transplantation. 2010 Nov 15;90(9):993-9. doi: 10.1097/TP.0b013e3181f6a058.

Abstract

BACKGROUND

Little is known about the long-term outcomes of obese living kidney donors (OLKDs). We undertook this study to describe renal outcomes of OLKDs several years after donation.

METHODS

We invited 101 OLKDs for follow-up health evaluation.

RESULTS

Thirty-six subjects (35.6%) completed evaluation at 6.8±1.5 years postdonation. The mean estimated glomerular filtration rate (eGFR) using the abbreviated modification of diet in renal disease (MDRD) equation (MDRD-eGFR) at follow-up was 72.1±16.3 (range: 42-106) mL/min per 1.73 m, and 47.2% of subjects had an MDRD-eGFR of 30 to 59. The absolute decrease in MDRD-eGFR from the time of donation to follow-up was 27.2 ± 13.1 mL/min per 1.73 m (P<0.001 on paired t test), which represents a 29.2% drop in the serial MDRD-eGFRs. Seven subjects (19.4%) had microalbuminuria (30-300 μg/mg creatinine). Subjects with microabuminuria were more likely to have MDRD-eGFR of less than 60 mL/min per 1.73 m (P=0.021). Subjects whose body mass index was greater than or equal to 35 kg/m (n=14) were found to have an absolute decrement in MDRD-eGFR similar to those with body mass index less than 35 kg/m (31.5 ± 15.6 and 24.7 ± 11.0 mL/min/1.73 m, respectively; P=not significant). Fifteen (41.6%) were hypertensive at follow-up.

CONCLUSIONS

On medium-term follow-up, a large proportion of OLKDs will have a MDRD-eGFR of less than 60 mL/min per 1.73 m, and the likelihood increases markedly among those who develop microalbuninuria. This raises concern for hyperfiltration injury. Furthermore, OLKDs experience a substantial incidence of hypertension. Caution is advised in selecting OLKDs pending further data on long-term outcomes.

摘要

背景

对于肥胖活体供肾者(OLKD)的长期预后,我们知之甚少。本研究旨在描述 OLKD 捐献后数年的肾脏结局。

方法

我们邀请了 101 名 OLKD 进行随访健康评估。

结果

36 名受试者(35.6%)在捐献后 6.8±1.5 年完成了评估。使用简化肾脏病膳食改良公式(MDRD)估算的肾小球滤过率(eGFR)(MDRD-eGFR)在随访时为 72.1±16.3(范围:42-106)mL/min/1.73m,47.2%的受试者的 MDRD-eGFR 为 30 至 59。与捐献时相比,MDRD-eGFR 在随访时的绝对下降为 27.2±13.1 mL/min/1.73m(配对 t 检验,P<0.001),这代表 MDRD-eGFR 的连续下降了 29.2%。7 名受试者(19.4%)有微量白蛋白尿(30-300μg/mg 肌酐)。微量白蛋白尿的受试者更有可能出现 MDRD-eGFR 低于 60 mL/min/1.73m(P=0.021)。体重指数(BMI)大于或等于 35 kg/m(n=14)的受试者发现,与 BMI 小于 35 kg/m 的受试者相比,MDRD-eGFR 的绝对下降量相似(分别为 31.5±15.6 和 24.7±11.0 mL/min/1.73m,P=无显著差异)。15 名(41.6%)受试者在随访时患有高血压。

结论

在中期随访中,很大一部分 OLKD 的 MDRD-eGFR 将低于 60 mL/min/1.73m,而在出现微量白蛋白尿的患者中,这一可能性显著增加。这引起了对高滤过损伤的关注。此外,OLKD 发生高血压的发生率相当高。在等待进一步的长期结果数据时,应谨慎选择 OLKD。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验